Patent ID: 9131929
Filing Date: 2015-09-15
Classification: A61B,A61F,A61K,A61L,A61P,C12Y

Abstract:
1. A device for treating wounded internal tissue in a mammal comprising: (a) an applicator; and (b) a haemostatically effective amount of a casted haemostatic material, wherein said casted haemostatic material consisting essentially of a substantially homogeneous mixture of a fibrinogen component and a fibrinogen activator, wherein said fibrinogen component is present in an amount between 26 to about 450 mg per square centimeter of the surface intended to contact the wounded internal tissue being treated and wherein the fibrinogen activator is employed between about 0.0087-1.000 mg fibrinogen component, and wherein said fibrinogen component and fibrinogen activator are cooled to about 4° C.+/−2° C. before casting.